Published in Health Serv Res on October 01, 2002
Efficient utilization of the expanded criteria donor (ECD) deceased donor kidney pool: an analysis of the effect of labeling. Am J Transplant (2010) 0.84
The impact of donor policies in Europe: a steady increase, but not everywhere. BMC Health Serv Res (2008) 0.79
A Standardized Donor Designation Ratio to Assess the Performance of Driver's License Agencies. Transplant Proc (2017) 0.75
The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA (1992) 1.54
Estimation and characterization of the potential renal organ donor pool in Pennsylvania. Report of the Pennsylvania Statewide Donor Study. Transplantation (1991) 1.46
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Options for increasing organ donation: the potential role of financial incentives, standardized hospital procedures, and public education to promote family discussion. Milbank Q (1995) 1.08
The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation (1991) 1.05
A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation (1999) 0.93
Xenotransplantation. Br J Surg (2000) 0.91
Benchmarking organ procurement organizations: a national study. Health Serv Res (1999) 0.83
Using USRDS generated hospitalization tables to compare local dialysis patient hospitalization rates to national rates. Kidney Int (1996) 0.81
Trauma registries and organ transplantation. JAMA (1990) 0.81
Medicare and Medicaid programs; conditions of coverage for organ procurement organizations (OPOs)--HCFA. Final rule with comment period. Fed Regist (1996) 0.80
The structure and effectiveness of the U.S. organ procurement system. Inquiry (1985) 0.80
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med (2003) 3.88
Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc (2007) 2.90
Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis (2008) 2.42
Increased spending on health care: how much can the United States afford? Health Aff (Millwood) (2003) 2.41
The effects of nurse staffing on adverse events, morbidity, mortality, and medical costs. Nurs Res (2003) 2.39
Continuity of care and the risk of preventable hospitalization in older adults. JAMA Intern Med (2013) 2.27
Competitive spillovers across non-profit and for-profit nursing homes. J Health Econ (2003) 2.15
Approval times for new drugs: does the source of funding for FDA staff matter? Health Aff (Millwood) (2004) 1.95
Using knowledge of multiple levels of variation in care to target performance incentives to providers. Med Care (2008) 1.53
Randomized controlled effectiveness trial of reciprocal peer support in heart failure. Circ Heart Fail (2013) 1.51
Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol (2012) 1.47
Case management: effects of improved risk and value information. Gerontologist (2003) 1.42
Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction. Manag Care Interface (2002) 1.39
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2016) 1.37
Cost-effectiveness of hospital pay-for-performance incentives. Med Care Res Rev (2006) 1.37
Primary care practice coordination versus physician continuity. Fam Med (2004) 1.30
A flexible two-part random effects model for correlated medical costs. J Health Econ (2009) 1.26
Effect of part-time practice on patient outcomes. J Gen Intern Med (2003) 1.25
Physician performance assessment: nonequivalence of primary care measures. Med Care (2003) 1.25
Increased spending on health care: long-term implications for the nation. Health Aff (Millwood) (2009) 1.23
How active resisters and organizational constipators affect health care-acquired infection prevention efforts. Jt Comm J Qual Patient Saf (2009) 1.22
Induced smoothing for the semiparametric accelerated failure time model: asymptotics and extensions to clustered data. Biometrika (2009) 1.21
Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach. Med Care (2002) 1.19
Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr (2005) 1.17
The importance of leadership in preventing healthcare-associated infection: results of a multisite qualitative study. Infect Control Hosp Epidemiol (2010) 1.13
Applying value-based insurance design to low-value health services. Health Aff (Millwood) (2010) 1.11
The financial implications of coverage of smoking cessation treatment by managed care organizations. Inquiry (2004) 1.10
Consumers, health insurance and dominated choices. J Health Econ (2011) 1.09
To test or not to test? The role of attitudes, knowledge, and religious involvement among U.S. adults on intent-to-obtain adult genetic testing. Health Educ Behav (2011) 1.03
The effect of Medicare's prospective payment system on discharge outcomes of skilled nursing facility residents. Inquiry (2005) 1.00
Factor substitution in nursing homes. J Health Econ (2006) 1.00
Pelvic floor consequences of cesarean delivery on maternal request in women with a single birth: a cost-effectiveness analysis. J Womens Health (Larchmt) (2010) 0.94
Translating infection prevention evidence into practice using quantitative and qualitative research. Am J Infect Control (2006) 0.94
A partitioning deletion/substitution/addition algorithm for creating survival risk groups. Biometrics (2012) 0.94
A copayment increase for prescription drugs: the long-term and short-term effects on use and expenditures. Inquiry (2005) 0.91
Perception and use of guidelines and interprofessional dynamics: assessing their roles in guideline adherence in delivering medications in nursing homes. Qual Manag Health Care (2007) 0.91
Effect of nursing home ownership on hospitalization of long-stay residents: an instrumental variables approach. Int J Health Care Finance Econ (2014) 0.89
Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. Am J Kidney Dis (2012) 0.88
Do corporate chains affect quality of care in nursing homes? The role of corporate standardization. Health Care Manage Rev (2007) 0.88
STARS: strategies to assist navy recruits' success. Mil Med (2007) 0.86
Decomposing trends in nonmarital fertility among Latinas. Perspect Sex Reprod Health (2009) 0.86
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2017) 0.84
A smoothing expectation and substitution algorithm for the semiparametric accelerated failure time frailty model. Stat Med (2012) 0.84
Comparative cost-effectiveness analysis of descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States. Am J Ophthalmol (2012) 0.84
The price sensitivity of Medicare beneficiaries: a regression discontinuity approach. Health Econ (2012) 0.83
Conditional GEE for recurrent event gap times. Biostatistics (2009) 0.83
Nurse-Enhanced Memory Intervention in Heart Failure: the MEMOIR study. J Card Fail (2011) 0.83
Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls. Am J Kidney Dis (2010) 0.82
Activity of daily living trajectories surrounding acute hospitalization of long-stay nursing home residents. J Am Geriatr Soc (2013) 0.81
It was the best of times, it was the worst of times: a tale of two years in not-for-profit hospital financial investments. Health Care Manage Rev (2008) 0.81
A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci (2009) 0.81
Flexible hazard regression modeling for medical cost data. Biostatistics (2002) 0.81
Classical conditioning through auditory stimuli in Drosophila: methods and models. J Exp Biol (2011) 0.81
Understanding the basic case-mix adjustment for the composite rate. Am J Kidney Dis (2006) 0.80
Workers on the margin: who drops health coverage when prices rise? Inquiry (2010) 0.80
Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial). Am J Cardiol (2005) 0.79
Generic utilization and cost-sharing for prescription drugs. Adv Health Econ Health Serv Res (2010) 0.79
Predictors of chain acquisition among independent dialysis facilities. Health Serv Res (2010) 0.79
Effect of Medicaid payment on rehabilitation care for nursing home residents. Health Care Financ Rev (2007) 0.78
Mortality predictions on admission as a context for organizing care activities. J Hosp Med (2012) 0.78
Implementation of a mortality prediction rule for real-time decision making: feasibility and validity. J Hosp Med (2014) 0.78
What does a serum sodium cost? J Am Soc Nephrol (2008) 0.78
A positive deviance perspective on hospital knowledge management: analysis of Baldrige Award recipients 2002-2008. J Healthc Manag (2013) 0.77
Drawing from Freirian empowerment methods to develop and use innovative learning maps: increasing enrollment of uninsured children on Detroit's eastside. Health Promot Pract (2006) 0.77
Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. J Thorac Oncol (2014) 0.77
The Care Span: Lower Hispanic participation in Medicare Part D may reflect program barriers. Health Aff (Millwood) (2014) 0.76
Healthcare resource use among heart failure patients in a randomized pilot study of a cognitive training intervention. Heart Lung (2013) 0.76
Do Nursing Home Chain Size and Proprietary Status Affect Experiences With Care? Med Care (2016) 0.75
Communicating effectively and managing care. Am J Manag Care (2004) 0.75
Predictors and outcomes of emergency department visits within 30 days following percutaneous coronary intervention. Am J Cardiol (2006) 0.75
The Effect of False-positive Mammograms on Antidepressant and Anxiolytic Initiation. Med Care (2017) 0.75
The association of debt financing with not-for-profit hospitals' operational and capital-investment efficiency. J Health Care Finance (2004) 0.75
Understanding meaningful outcomes. Am J Manag Care (2010) 0.75
Financial preconditions for successful community initiatives for the uninsured. J Healthc Manag (2007) 0.75
Clinical efficacy and cost-effectiveness of rosuvastatin. Expert Rev Pharmacoecon Outcomes Res (2007) 0.75
Training welfare caseworkers in service excellence: increasing children's Medicaid coverage. J Health Care Poor Underserved (2006) 0.75
Trends and predictors of quality of care in VA nursing homes related to serious mental illness. Med Care (2013) 0.75
Getting the right services covered by health insurance. Am J Manag Care (2010) 0.75
The association of debt financing with not-for-profit hospitals' provision of uncompensated care. J Health Care Finance (2004) 0.75
Healthcare utilization in community-acquired pneumonia episodes of care: a comparison across the continuum of managed care. Med Care (2009) 0.75
Current marketing practices in the nursing home sector. J Healthc Manag (2006) 0.75
When payment systems collide: the effect of hospitalization on anemia in renal dialysis patients. Med Care (2010) 0.75
Duration of evidence-based medical therapy and the hazard for atherothrombotic events following percutaneous coronary intervention. Int J Cardiol (2010) 0.75
Finance theory and hospital cash balances. J Health Care Finance (2013) 0.75
Cash holdings of not-for-profit hospitals. J Health Care Finance (2011) 0.75
The effects of preferred provider organizations on costs and utilization of hysterectomy. Nurs Econ (2004) 0.75
Costs of physician services in pharmacoeconomic analyses. Expert Rev Pharmacoecon Outcomes Res (2005) 0.75
Cost accounting for end-of-life care: recommendations to the field by the Cost Accounting Workgroup. J Health Care Finance (2004) 0.75